Drug
Tenecteplase
Tenecteplase: highest development phase Phase 3, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tenecteplase NCT07361302 | Phase 3 | Acute Ischemic Stroke |
Latest
No recent events.
Follow Tenecteplase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.